Clinical Trial

High-flow Nasal Cannula Oxygen Therapy Versus Conventional Oxygen Therapy in High-altitude Pulmonary Edema

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate whether High-flow Nasal Cannula Oxygen Therapy (HFNC) provides superior respiratory support compared to Conventional Oxygen Therapy (COT) in patients with High-Altitude Pulmonary Edema (HAPE).
Protocol Amendment History 2 changes
critical Primary endpoint(s) modified 2026-08-12
critical Recruitment opened 2026-05-05
Trial Details
NCT Number NCT07536477
Lead Sponsor Third Military Medical University
Conditions High-altitude Pulmonary Edema
Enrollment 208 participants
Start Date 2026-04-25
Primary Completion 2029-04-22 (estimated)
Study Completion 2029-04-22 (estimated)
Updated on ClinicalTrials.gov 2026-08-11